What causes xlh

Overview

X-linked hypophosphatemia (XLH) is a rare inherited disorder that affects bones and teeth. It is characterized by a deficiency of phosphate in the blood (hypophosphatemia), which leads to impaired bone mineralization. This deficiency causes the bones to soften and weaken, a condition known as rickets in children and osteomalacia in adults. The 'X-linked' part of the name refers to the gene mutation being located on the X chromosome, which influences how the disorder is inherited.

What Causes XLH? The PHEX Gene and Phosphate Regulation

The root cause of XLH lies in mutations of the PHEX gene. This gene provides instructions for making an enzyme (a type of protein) that plays a crucial role in regulating phosphate levels in the body. Phosphate is an essential mineral needed for building strong bones and teeth, as well as for numerous other bodily functions, including energy production and cell growth.

The Role of the PHEX Gene

The PHEX enzyme is primarily active in the bones and teeth. It is believed to be involved in breaking down a hormone called fibroblast growth factor 23 (FGF23). FGF23 is a key regulator of phosphate metabolism. Specifically, FGF23 acts on the kidneys to reduce the reabsorption of phosphate back into the bloodstream, thereby increasing the amount of phosphate excreted in the urine. FGF23 also influences how much phosphate is absorbed from the diet in the intestines.

How PHEX Mutations Lead to Hypophosphatemia

In individuals with XLH, mutations in the PHEX gene lead to a non-functional or less functional PHEX enzyme. When the PHEX enzyme is not working correctly, it cannot effectively break down FGF23. This results in abnormally high levels of active FGF23 circulating in the blood. The elevated FGF23 then acts on the kidneys, causing them to excrete too much phosphate in the urine and reabsorb too little phosphate back into the body. Simultaneously, the excess FGF23 can also interfere with vitamin D metabolism, further impairing phosphate absorption from the gut. This combination of increased phosphate loss and reduced absorption leads to chronically low levels of phosphate in the blood, known as hypophosphatemia.

Consequences of Low Phosphate Levels

With insufficient phosphate available in the bloodstream, the body cannot properly mineralize bone tissue. Normally, calcium and phosphate salts crystallize to form the hard, rigid structure of bone. In XLH, this mineralization process is severely impaired, resulting in bones that are soft, weak, and prone to bending and fracture. This condition is called rickets when it occurs during childhood while bones are still growing, and osteomalacia in adults whose bones have stopped growing but continue to remodel.

Inheritance Pattern: X-linked Dominant

XLH is inherited in an X-linked dominant pattern. This means the gene mutation is located on the X chromosome, one of the two sex chromosomes (females have XX, males have XY). A dominant inheritance pattern means that only one copy of the mutated gene is needed to cause the disorder.

• Inheritance from Mothers: A mother with XLH has one normal copy of the PHEX gene and one mutated copy on her X chromosomes. Each child has a 50% chance of inheriting the mutated gene and developing XLH. Sons will inherit the mutated X chromosome from their mother, and daughters will inherit one mutated X chromosome from their mother and one normal X chromosome from their father.
• Inheritance from Fathers: A father with XLH has the mutated gene on his single X chromosome. He will pass this mutated X chromosome to all of his daughters, meaning all his daughters will have XLH. He will pass his Y chromosome to all of his sons, so his sons will not inherit XLH from him.

Because males have only one X chromosome, they are typically more severely affected by X-linked disorders than females, who have two X chromosomes. However, the severity of XLH can vary widely among affected individuals, regardless of sex.

Spontaneous Mutations

While most cases of XLH are inherited, it is also possible for the disorder to arise from a new, spontaneous mutation in the PHEX gene. In these instances, neither parent has the mutation, and the affected individual is the first in their family to have XLH. These spontaneous mutations account for a smaller percentage of XLH cases.

Symptoms and Diagnosis

The symptoms of XLH can vary greatly in severity and typically become apparent in infancy or early childhood. Common signs include:

• Bowed legs or knock-knees
• Bone pain and tenderness
• Short stature and delayed growth
• Genu varum (bowing of the legs)
• Dental problems, such as delayed tooth eruption, enamel defects, and abscesses
• Rickets (softening of bones)
• Muscle weakness
• Joint pain and stiffness

Diagnosis is usually made based on clinical symptoms, family history, characteristic X-ray findings, and blood tests that reveal low phosphate levels and normal or near-normal calcium levels. Genetic testing can confirm the presence of mutations in the PHEX gene.

Management and Treatment

While there is no cure for XLH, treatment focuses on managing symptoms and preventing complications. This typically involves lifelong treatment with phosphate supplements and active forms of vitamin D (like calcitriol) to help increase phosphate absorption and improve bone mineralization. Early diagnosis and consistent treatment are crucial for improving outcomes and quality of life for individuals with XLH.